NASDAQ:INM - Nasdaq - CA4576377002 - Common Stock - Currency: USD
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Get a pulse on the US markets on Tuesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.
InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognitive function in models.
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform.
August 20, 2024 7:30 AM EDT | Source: InMed Pharmaceuticals High bioavailability of INM-901 oral formulation provides similar drug concentration levels in the brain as intraperitoneal (IP) injection Vancouver, British Columbia–(Newsfile Corp. – August 20, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of […]
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!
InMed Pharmaceuticals just reported results for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips InMed Pharmaceuticals (NASDAQ:INM) just reported results for the third quarter ...